Claritin Reditabs Side Effects

Please note - some side effects for Claritin Reditabs may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

Side Effects of Claritin Reditabs - for the Consumer

Claritin Reditabs Orally Disintegrating Tablets

All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with Claritin Reditabs Orally Disintegrating Tablets. Seek medical attention right away if any of these SEVERE side effects occur when using Claritin Reditabs Orally Disintegrating Tablets:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe or persistent dizziness.

Side Effects by Body System

Nervous system

Nervous system side effects have included headache in approximately 7% of treated patients. Usually, loratadine has not been shown to cause significant drowsiness, sedation, or impair psychomotor skills.

One study of second generation antihistamines reported cetirizine was 3.5 times more likely and acrivastine 2.8 times more likely to result in sedation than loratadine. There was no significant difference in incidence of sedation between loratadine and fexofenadine.

Cardiovascular

One study reported prolongation of the QT interval when larger than recommended (20 mg per day) doses of loratadine were administered with nefazodone (300 mg every 12 hours).

Cardiovascular side effects have included hypertension, hypotension, palpitation, supraventricular tachyarrhythmias, syncope and tachycardia.

Gastrointestinal

Gastrointestinal side effects have included rare reports of nausea and dry mouth.

Hepatic

Hepatic side effects have included rare reports of jaundice, hepatitis, and hepatic necrosis.

Two cases of necroinflammatory liver injury have been reported in patients taking loratadine. One case presented within 2 weeks of starting loratadine therapy and the other occurred 14 months after the start of therapy. Liver transplantation was necessary in one patient.

Dermatologic

Dermatologic side effects have included a case report of a fixed drug eruption.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.